ELPEN
Dimitris Pentafragkas serves as the Formulation Development Supervisor and BoD Member at Elpen Pharmaceutical Co. Inc. since September 2021, after a previous role as a Production Officer in early 2020. Prior experience includes working as a Formulation Scientist in the R&D Formulation Department, where Dimitris conducted in vitro tests, engaged in formulation development activities, and coordinated quality control and assurance processes. An internship in the R&D Analytical Department involved further in vitro testing for both tablets and dry powder inhalation products. Dimitris holds a Master's degree in Pharmaceutics from UCL and a Bachelor of Science from the University of Crete, complemented by a high school diploma from the Hellenic American Educational Foundation Athens College.
This person is not in any offices
ELPEN
3 followers
ELPEN is the leading Greek pharmaceutical company founded in 1965. The company's vision is to actively contribute to advancing health services, while its mission is to create effective treatments that enhance patients' lives worldwide.